News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alexion Pharmaceuticals Inc. (ALXN) Announces The Appointment Of John T. Mollen To Its Board Of Directors



4/18/2014 6:27:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the appointment of John “Jack” T. Mollen to the Company’s Board of Directors, effective immediately. The Company also announced that Joseph A. Madri, Ph.D., M.D. and Larry L. Mathis, will retire at the conclusion of the current term on May 5, 2014, after 22 years and 10 years of service to the Company, respectively.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES